While PARP inhibitors offer a promising treatment option, they can also cause side effects. Common side effects include nausea, fatigue, anemia, and low blood cell counts. More severe but less common side effects may include increased risk of myelodysplastic syndrome or acute myeloid leukemia. Ongoing monitoring and supportive care are essential for managing these adverse effects.
